Page 19 - Deena Beasley News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Deena beasley. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Deena Beasley Today - Breaking & Trending Today

Amgen quarterly revenue rises 6%, profit beats Street estimates

(Reuters) -Amgen, which is facing U.S. Federal Trade Commission (FTC) delays to its planned acquisition of Horizon Therapeutics, on Thursday reported higher quarterly profit on strong sales of treatments for cholesterol, osteoporosis and other drugs. The biotech company, which slightly raised its outlook for full-year revenue and profit, said it currently expects the Horizon deal to close by mid-December. For the second quarter, Amgen reported revenue of $6.99 billion, up 6% from a year earlier, exceeding analysts' estimates of $6.68 billion, according to Refinitiv data. ....

United States , Peter Griffith , Deena Beasley , Us Federal Trade Commission , Trade Commission , Horizon Therapeutics , Chief Financial Officer Peter Griffith , Wall Street , Bill Berkrot ,

Amgen quarterly revenue rises 6%, profit beats Street estimates

(Reuters) -Amgen, which is facing U.S. Federal Trade Commission (FTC) delays to its planned acquisition of Horizon Therapeutics, on Thursday reported higher quarterly profit on strong sales of treatments for cholesterol, osteoporosis and other drugs. The biotech company, which slightly raised its outlook for full-year revenue and profit, said it currently expects the Horizon deal to close by mid-December. For the second quarter, Amgen reported revenue of $6.99 billion, up 6% from a year earlier, exceeding analysts' estimates of $6.68 billion, according to Refinitiv data. ....

United States , Deena Beasley , Peter Griffith , Us Federal Trade Commission , Trade Commission , Horizon Therapeutics , Chief Financial Officer Peter Griffith , Wall Street , Bill Berkrot ,

Gilead quarterly profit falls on COVID sales drop, legal settlement charge

(Reuters) -Gilead Sciences on Thursday reported lower second-quarter profit as costs from a legal settlement and sharply lower sales of its COVID-19 treatment offset another strong performance by HIV drugs. The drugmaker raised its full-year revenue forecast, even as it trimmed its estimate for COVID antiviral Veklury due to lower pandemic-related hospitalizations. Gilead reported second-quarter earnings of $1.34 per share excluding items, on total revenue of $6.6 billion, down from $1.58 a share and revenue of $6.26 billion in the year-ago quarter. ....

United States , Deena Beasley , Gilead Sciences On , Wall Street , Reporting By Deena Beasley , Michael Erman , Bill Berkrot ,

Experimental drug works best for Alzheimer's patients treated as early as possible

Experimental drug works best for Alzheimer's patients treated as early as possible
gazette.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gazette.com Daily Mail and Mail on Sunday newspapers.

Noord Holland , United States , Ludwig Burger , Susan Kohlhaas , Eli Lilly , Anne White , Deena Beasley , Liz Coulthard , Reisa Sperling , Julie Steenhuysenediting , Caroline Humer , Indiana University School Of Medicine , University Of Bristol , York Stock Exchange , Un World Health Organization , Alzheimer Research United Kingdom , New York Stock Exchange , Alzheimer Research , Alzheimer Association , Alzheimer Association International Conference , Drug Administration , Association International Conference , Research United Kingdom , Liana Apostolova , Indiana University School , New York Stock ,

Lilly Drug Slows Alzheimer's By 60% For Mildly Impaired Patients In Trial

Lilly Drug Slows Alzheimer's By 60% For Mildly Impaired Patients In Trial
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Noord Holland , United States , Deena Beasley , Eli Lilly , Anne White , Caroline Humer , Liz Coulthard , University Of Bristol , Drug Administration , York Stock Exchange , Alzheimer Association International Conference , New York Stock Exchange , Indiana University School Of Medicine , Alzheimer Association , Liana Apostolova , Indiana University School , Association International Conference , New York Stock , Bill Berkrot , Will Dunham ,